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Abstract
This article reviews quantitative methods to estimate the basic reproduction
number of pandemic influenza, a key threshold quantity to help determine the
intensity of interventions required to control the disease. Although it is difficult
to assess the transmission potential of a probable future pandemic, historical epi-
demiologic data is readily available from previous pandemics, and as a reference
quantity for future pandemic planning, mathematical and statistical analyses of
historical data are crucial. In particular, because many historical records tend
to document only the temporal distribution of cases or deaths (i.e. epidemic
curve), our review focuses on methods to maximize the utility of time-evolution
data and to clarify the detailed mechanisms of the spread of influenza.
First, we highlight structured epidemic models and their parameter estima-
tion method which can quantify the detailed disease dynamics including those
we cannot observe directly. Duration-structured epidemic systems are subse-
quently presented, offering firm understanding of the definition of the basic and
effective reproduction numbers. When the initial growth phase of an epidemic is
investigated, the distribution of the generation time is key statistical information
to appropriately estimate the transmission potential using the intrinsic growth
rate. Applications of stochastic processes are also highlighted to estimate the
transmission potential using similar data. Critically important characteristics
of influenza data are subsequently summarized, followed by our conclusions to
suggest potential future methodological improvements.
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1 Introduction
Influenza epidemics are observed around the world during the wintertime and with a
strong seasonal component in temperate regions [1][2]. Influenza is a disease caused
by the influenza virus, an RNA virus belonging to the Orthomyxoviridae [3]. Many
features are common with those of the paramyxovirus infections of the acute upper
respiratory tract. Typical symptoms of the disease are characterized by fever, myal-
gia, severe malaise, non-productive cough, and sore throats. The disease spreads when
an infected individual coughs or sneezes and sends the virus into the air, and other
susceptible individuals inhale the virus. The virus is also believed to be transmitted
when a person touches a surface that is contaminated with the virus (e.g. door knob,
etc.) and then touches the nose or eyes. Infected individuals can transmit the virus
almost within a day following infection (i.e. latent period). Although it is generally
believed that infected individuals can pass the virus for 3-7 days following symptom on-
set, there is some uncertainty on the duration of the infectious period. The generation
time (i.e. sum of latent and infectious periods) for influenza, reported and assumed in
the literature, ranges from 3 days [4][5][6] to about 6 days [7][8].
Individuals that are infected with influenza are believed to become permanently
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immune against the specific virus strain. Hence, the virus is able to persist in the human
population through relatively minor (single point) mutations in the virus composition
known as drifts. Influenza (sub)types A/H3N2, A/H1N1 and B are currently co-
circulating in the human population [9]. Major changes in the virus composition via
recombination or gene reassortment processes (known as genetic shifts) can lead to
the emergence of novel influenza viruses with the potential of generating dramatic
morbidity and mortality levels around the world [3].
The 1918-19 influenza pandemic known as the Spanish influenza caused by the in-
fluenza virus A (H1N1) has been the most devastating in recent history with estimated
worldwide mortality ranging from 20 to 100 million deaths [10][11] with a case fatality
of 2-6 percent [12][13]. The worldwide 1918 influenza pandemic spread in three waves
starting from Midwestern United States in the spring of 1918 [14][15]. The deadly
second wave began in late August probably in France while the third wave is generally
considered as part of normal more scattered winter outbreaks similar to those observed
after the 1889/90 pandemic [14]. Subsequent pandemics during the 20th century are
attributed to subtyes A (H2N2) from 1957-58 (Asian influenza) and A (H3N2) in 1968
(Hong Kong influenza) [16].
The ability to quickly detect and institute control efforts at the early stage of an
influenza pandemic is directly linked to the final levels of morbidity and mortality in
the population [13]. To appropriately assess the disaster size of a probable future pan-
demic, we have to quantify the transmission potential (and its associated uncertainty).
Although it is difficult to directly measure the transmissibility of a future pandemic,
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historical epidemiologic data is readily available from previous pandemics, and as a
reference quantity for future pandemic planning, mathematical and statistical analyses
of the historical data can offer various insights. In particular, because many historical
records tend to document only the temporal distribution of cases or deaths (i.e. epi-
demic curve), we modelers have faced with a difficult need to clarify the mechansms of
the spread of influenza using such time-evolution data alone. In this paper, we review
a number of mathematical and statistical methods for the estimation of the transmis-
sion potential of pandemic influenza, focusing on theoretical techniques to maximize
the utility of the temporal distribution of influenza cases. The methods that have
been incorporated in this review include the applications of epidemiologically struc-
tured epidemic models, explicitly duration-structured epidemic system, and stochastic
processes (i.e. branching and counting processes). Whereas this review does not cover
the spread of influenza in space, spatial heterogeneity in transmission and the growing
interest in the role of contact network are briefly discussed as the future challenge.
2 On the definition of the transmission potential
The basic reproduction number, R0 (pronounced as R nought), is a key quantity used
to estimate transmissibility of infectious diseases. Theoretically, R0 is defined as the
average number of secondary cases generated by a single primary case during its entire
period of infectiousness in a completely susceptible population [17]. As the epidemic
progresses, the number of susceptible individuals is decreased due to infection, and the
reproduction number decays following R(t) = R0S(t)/S(0) where S(t) and S(0) are,
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respectively, the number of susceptible individuals at time t and before the epidemic
starts; the latter is equivalent to the total population size N given that all individuals
are susceptible before the beginning of an epidemic. Clearly, this definition only applies
to (novel) emerging infectious diseases (e.g. the epidemic of severe acute respiratory
syndrome (SARS) from 2002-3) or re-emerging infectious diseases that had not circu-
lated in the population in question for long enough to allow for residual immunity in
the population to disappear due to births and deaths.
The reproduction number is directly related to the type and intensity of interven-
tions necessary to control an epidemic since the objective is to make R(t) < 1 as soon
as possible. To achieve R(t) < 1, one or a combination of control strategies may be
implemented. For example, one of the best known uses of R0 is in determining the
critical coverage of immunization required to eradicate a disease in a randomly mixing
population. That is, when vaccine is available against a disease in question, it is of
interest to estimate the critical proportion of the population that needs to be vacci-
nated (i.e. vaccination coverage) in order to attain R < 1 [18][19]. For example, in
the U.S prior to 1963, a vaccine against measles was not available and hence recurrent
epidemics of measles were observed with approximately 3 − 4 million cases per year
and a mean of 450 deaths. The introduction of the vaccine in the U.S. reduced the
incidence by 98 percent.
The critical vaccination coverage, pc (in a randomly mixing population) can be es-
timated from the R0 of the disease in question as follows [20]:
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pc >
1
ǫ
(
1−
1
R0
)
(1)
where ǫ is the efficacy (i.e. direct effectiveness) of vaccination [21]. pc given in (1)
suggests that the disease could be eradicated even when all susceptible individuals are
not vaccinated. The protection conferred to the population by achieving a critical vac-
cination coverage is known as herd immunity [22][23].
A brief history of the theoretical developments on the basic reproduction number
and its analytical computation via epidemic modeling is given elsewhere [23][24][25].
The mathematical definition and calculation of R0 using next-generation arguments
is described initially by Odo Diekmann and his colleagues [17][26], where R0 is the
dominant eigenvalue of the resulting next generation matrix. Further elaborations and
reviews can be found elsewhere [27][28][29][30][31][32][33]. Classically, rather than the
threshold phenomena, R0 was used to suggest the severity of an epidemic, because the
proportion of those experiencing infection at the end of an epidemic depends only on
R0 [34] (see Section 3).
Statistical methods to quantitatively estimate R0 have been reviewed by Klaus Di-
etz [35]. Depending on the characteristics of data and underlying assumptions of the
models, R0 can be estimated using various different approaches [36]. In addition to the
final size equation, R0 of an epidemic of newly emerging disease can be estimated from
the intrinsic growth rate [4][6][8][18][37][38], which is also referred to as the rate of
natural increase, suggesting the natural growth rate of infected individuals in a fully
susceptible population (discussed in Section 4). Moreover, for simple epidemic models
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with relatively few parameters, R0 can be estimated with other unobservable quantities
by rigorous curve fitting of model equations to the observed epidemic data (discussed
in Section 3)[38][39][40]. Not only R0 but also R(t) can be estimated from the temporal
distribution of infectious diseases, reconstructing the transmission network or inferring
the time-inhomogeneous number of secondary transmissions [41][42][43][44].
To estimate the basic reproduction number of endemic diseases, different approaches
are taken. One would need first to carry out serological surveys to quantify the frac-
tion of the population that is effectively protected against infection (i.e. age- and/or
time-specific proportion of those possessing acquired immunity needs to be estimated).
Through this effort, the force of infection, the rate at which susceptible individuals
get infected, is estimated [45]. For example, this is the case for rubella, mumps and
measles (that are still circulating in some regions of the world even when high effective
vaccination coverage is achieved). Although the estimation of R0 for endemic diseases
is out of the scope of this review, methodological details and the applications to esti-
mate the force of infection and R0 can be found elsewhere [46][47][48][49][50][51][52].
In practice, the reproduction number denoted simply by R and defined as the num-
ber of secondary cases generated by a primary infectious cases in a partially protected
population might be useful. R can also be estimated from the initial growth phase of an
epidemic in such a partially immunized population. In a randomly mixing population,
the relationship between the basic reproduction number (R0) and the reproduction
number (R) is given by R = (1−p)R0 where p is the proportion of the population that
is effectively protected against infection (in the beginning of an epidemic). Besides, for
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many recurrent infectious diseases including seasonal influenza, estimating the back-
ground immunity p in the population is extremely difficult due to cross-immunity of
antigenically-related influenza strains and vaccination campaigns.
With reagard to seasonal influenza, the reproduction number (R) over the last 3
decades has been estimated at 1.3 (SE 0.05) in the United States, France, and Australia
with an overall range of 0.9 − 2.0 [53]. An R estimate of 1.5 has been reported for a
single A/H3N2 season in France [54], and some estimates have been reported in the
range 1.4-2.6 for several consecutive influenza seasons in England and Wales [55][56].
A particularly high estimate of R has been suggested for the 1951 influenza epidemic
in England and Canada [57].
Because influenza pandemics such as the Spanish flu from 1918-19 are associated to
the emergence of novel influenza strains to which most of the population is susceptible,
it might be reasonable to assume that the reproduction number R ≈ R0. Previous
studies have estimated that R0 of the 1918-19 influenza pandemic ranged between 1.5
and 5.4 [8][38][40][39][57][58][59][60][61][62][63][64] depending on the specific location
and pandemic wave considered, type of data, estimation method, and level of spatial
aggregation, which has ranged from small towns to entire nations with several million
inhabitants. Table 1 lists estimates of R0 in recent studies. The variability of R0 es-
timates suggests that local factors, including geographic and demographic conditions,
could play an important role in disease spread [65][66][67]. In the following sections,
we review how these estimates are obtained and how we shall interpret the estimates,
starting from a simple structured epidemic model proposed in 1927.
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3 Estimating R0 using a structured epidemic model
Mathematical models provide a unique way to analyze the transmission dynamics and
study various different scenarios associated to the spread of communicable diseases
in population(s) [18][68][69]. The history of the mathematical modeling of infectious
diseases greatly remounts to the study of Sir Ronald Ross in 1911 [70] who invented
a classic malaria model and also discovered the mosquito-borne transmission mecha-
nisms of malaria. Employing a mass action principle for the spread of malaria, Ross
explored the effects of controling the mosquito population using simple mathematical
models [71]. Following his effort, Kermack and Mckendrick introduced a classical SIR
(susceptible-infectious-removed) epidemic model in 1927, which is most frequently uti-
lized in the present day, given by the following system of nonlinear ordinary differential
equations (ODEs) [72]:
dS(t)
dt
= −
βS(t)I(t)
N
dI(t)
dt
=
βS(t)I(t)
N
− γI(t)
dR(t)
dt
= γI(t)
(2)
where S(t) denotes susceptible individuals at time t; I(t), infected (assumed infectious)
individuals at time t; and R(t), recovered (assumed permanently immune) individuals
at time t; β is the transmission rate; γ the recovery rate; and N is the total popula-
tion size which is assumed constant for a closed population (i.e. a population without
immigration and emmigration). Susceptible individuals in contact with the virus en-
ter the infectious class (I) at the rate βI/N . That is, homogeneous mixing between
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individuals is assumed.
The basic reproduction number, R0, for the epidemic system (2) is given by the
product of the transmission rate and the mean infectious period. That is:
R0 =
β
γ
(3)
Classically, R0 has been known as a quantity to suggest severity of an epidemic [34].
Indeed, analytical expression of R0 in (3) is derived simply by solving the above system
(2). Replacing I(t) in the right hand side of dS(t)/dt by (1/γ)dR(t)/dt, we get
1
S(t)
dS(t)
dt
= −
β
γN
dR(t)
dt
(4)
Integrating both sizes of (4) from 0 to infinity,
ln
S(∞)
S(0)
= −
β
γN
(R(∞)− R(0)) (5)
Since S(∞) = N − R(∞), and because we assume S(0) = N and R(0) = 0, equation
(5) can be rewritten as
ln
N −R(∞)
N
= −
β
γ
R(∞)
N
(6)
In the above equation (6), final size, i.e., the proportion of those experiencing infection
among a total number of individuals in a community following a large scale epidemic,
is defined as p := R(∞)/N . That is,
ln(1− p) = −R0p (7)
Therefore, the following final size equation of an autonomous SIR (or SEIR) model
is obtained:
Rˆ0 =
− ln(1− p)
p
(8)
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Equation (8) can be analytically derived using both deterministic (models governed
by ODEs or partial differential equations (PDEs))[73] and stochastic models [74].
Despite the usefulness of (2), SIR assumptions given by ODEs are not always di-
rectly applicable to real data. One of the reasons include that there is no disease where
an infected individual can cause secondary transmission immediately after his/her in-
fection.
Accordingly, we have used slightly extended compartmental models in the previ-
ous studies to describe the transmission dynamics of the 1918-19 influenza pandemic
and estimate the reproduction number [38][39]. We now describe two different SEIR
(susceptible-exposed-infectious-removed) models that have been used to estimate the
reproduction number. The first model is the simple SEIR model, and the second model
accounts for asymptomatic and hospitalized individuals.
The simple SEIR model classifies individuals as susceptible (S), exposed (E), infec-
tious (I), recovered (R), and dead (D) [18]. Susceptible individuals in contact with the
virus enter the exposed class at the rate βI(t)/N , where β is the transmission rate,
I(t) is the number of infectious individuals at time t and N = S(t)+E(t)+ I(t)+R(t)
is the total population for any t. The entire population is assumed to be susceptible
at the beginning of the epidemic. Individuals in latent period (E) progress to the
infectious class at the rate k (where 1/k suggests the mean latent period). We as-
sume homogeneous mixing (i.e. random mixing) between individuals and, therefore,
the fraction I(t)/N is the probability of a random contact with an infectious individ-
ual in a population of size N . Since we assume that the time-scale of the epidemic
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is much faster than characteristic times for demographic processes (natural birth and
death), background demographic processes are not included in the model. Infectious
individuals either recover or die from influenza at the mean rates γ and δ, respectively.
Recovered individuals are assumed protected for the duration of the outbreak. The
mortality rate is given by δ = γ [CFP/(1-CFP)], where CFP is the mean case fatality
proportion. The transmission process can be modeled using the system of nonlinear
differential equations: 

dS(t)
dt
= −
βS(t)I(t)
N
dE(t)
dt
=
βS(t)I(t)
N(t)
− kE(t)
dI(t)
dt
= kE(t)− (γ + δ)I(t)
dR(t)
dt
= γI(t)
dD(t)
dt
= δI(t)
dC(t)
dt
= kE(t)
(9)
where C(t) is the cumulative number of infectious individuals. The basic reproduction
number of the above system (9) is given by the product of the mean transmission rate
and the mean infectious period, R0 = β/(γ + δ).
A more complex SEIR model (Figure 1) classifies individuals as susceptible (S),
exposed (E), clinically ill and infectious (I), asymptomatic and partially infectious
(A), diagnosed and reported (J), recovered (R), and death (D). The birth and natural
death rates are assumed to have a common rate µ (60-year life expectancy as in [38]).
The entire population is assumed susceptible at the beginning of the pandemic wave.
Susceptible individuals in contact with the virus progress to the latent class at the
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rate β(I(t) + J(t) + qA(t))/N where β is the transmission rate, and 0 < q < 1 is a
reduction factor in the transmissibility of the asymptomatic class (A). Since there is
no explicit evidence estimating and proving the effectiveness of public health interven-
tions, and because a high burden was placed upon the sanitary and medical sectors,
diagnosed/hospitalized individuals (J) are assumed equally infectious. Although it is
difficult to explicitly evaluate the difference in infectiousness between general commu-
nity and hospital, we roughly made this assumption since 78 percent of the nurses of the
San Francisco Hospital contracted influenza [75]. A more rigorous assumption requires
either statistical analysis of more detailed time-series data [76] or an epidemiological
comparison of specific groups by contact frequency [77]. The total population size at
time t is given by N = S(t)+E(t)+I(t)+A(t)+J(t)+R(t). We assumed homogeneous
mixing of the population and, therefore, the fraction (I(t) + J(t) + qA(t))/N is the
probability of a random contact with an infectious individual. A proportion 0 < ρ < 1
of latent individuals progress to the clinically infectious class (I) at the rate k while
the remaining (1−ρ) progress to the asymptomatic partially infectious class (A) at the
same rate k (fixed to 1/1.9 days−1 [8]). Asymptomatic cases progress to the recovered
class at the rate γ1. Clinically infectious individuals (class I) are diagnosed (reported)
at the rate α or recover without being diagnosed (e.g., mild infections, hospital refusals)
at the rate γ1. Diagnosed individuals recover at the rate γ2 = 1/(1/γ1 − 1/α) or die
at rate δ. The mortality rates were adjusted according to the case fatality proportion
(CFP), such that δ =
CFP
1− CFP
(µ+ γ2).
The transmission process can be modeled using the following system of nonlinear
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differential equations:

dS(t)
dt
= µN(t)−
βS(t)(I(t) + J(t) + qA(t))
N
− µS(t)
dE(t)
dt
=
βS(t)(I(t) + J(t) + qA(t))
N
− (k + µ)E(t)
dA(t)
dt
= k(1− ρ)E − (γ1 + µ)A(t)
dI(t)
dt
= kρE(t)− (α + γ1 + µ)I(t)
dJ(t)
dt
= αI(t)− (γ2 + δ + µ)J(t)
dR(t)
dt
= γ1(A(t) + I(t)) + γ2J(t)− µR(t)
dD(t)
dt
= δJ(t)
dC(t)
dt
= αI(t)
(10)
We assume the cumulative number of influenza notifications, our observed epidemic
data, is given by C(t). Seven model parameters (β, γ1, α, q, ρ, E(0), I(0)) are estimated
from the epidemic curve by least squares fitting as explained below. The reproduction
number for model (10) is given by (see [38]):
R =
βk
k + µ
{
ρ
(
1
γ1 + α + µ
+
α
(γ1 + α + µ)(γ2 + δ + µ)
)
+ (1− ρ)
(
q
γ1 + µ
)}
(11)
and the clinical reporting proportion is given by:
O =
α
α + γ1 + µ
. (12)
3.1 Parameter estimation
In the simplest manner, model parameters can be estimated via least-square fitting of
the model solution to the observed data. That is, one looks for the set of parameters Θˆ
whose model solution best fits the epidemic data by minimizing the sum of the squared
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differences between the observed data yt and the model solution C(t,Θ). That is, we
minimize:
X(Θ) =
n∑
t=1
(yt −C(t,Θ))
2 (13)
The standard deviation of the parameters can be estimated by computing the asymp-
totic variance-covariance AV (Θˆ) matrix of the least-squares estimate by [78]:
AV(Θˆ) = σ2(∇ΘC(Θ0) ∇ΘC(Θ0)
T)−1 (14)
which can be estimated by
σˆ2(∇ˆΘˆC(Θˆ)∇ˆΘˆC(Θˆ)T)−1 (15)
where n is the total number of observations, σˆ2 is the estimated variance, and ∇ˆC
are numerical derivatives of C. Estimates of Rˆ0 can be obtained by substituting the
corresponding individual parameter estimates into an analytical formula of R0. Fur-
ther, using the delta method [79], we can derive an expression for the variance of the
estimated basic reproduction number Rˆ0. An expression for the variance of R0 for the
simple SEIR model (Equations 9) is given by:
V (Rˆ0) ≈ Rˆ0
2
{
V (βˆ)
βˆ2
+
V (γˆ)
(γˆ + δˆ)2
+
V (δˆ)
(γˆ + δˆ)2
−(
2
βˆ(γˆ + δˆ)
)(Cov(γˆ, βˆ)−
βˆCov(δˆ, γˆ)
γˆ + δˆ
+ Cov(δˆ, βˆ))}. (16)
This expression depends on the variance (denoted by V ) of the individual parameter
estimates as well as their covariance (denoted by Cov).
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3.2 Bootstrap confidence intervals
Another method to generate uncertainty bounds on the reproduction number is gen-
erating bootstrap confidence intervals by generating sets of realizations of the best-fit
curve C(t) [80]. Each realization of the cumulative number of case notifications Ci(t)
(i = 1, 2, . . ., m) is generated as follows: for each observation C(t) for t = 2, 3, . . ., n
days generate a new observation C
′
i(t) for t ≥ 2 (C
′
i(1) = C(1)) that is sampled from a
Poisson distribution with mean: C(t)−C(t−1) (the daily increment in C(t) from day
t − 1 to day t). The corresponding realization of the cumulative number of influenza
notifications is given by Ci(t) =
∑t
j=1C
′
i(t) where t = 1, 2, 3, . . ., n. The reproduction
number was then estimated from each of 1000 simulated epidemic curves to generate
a distribution of R estimates from which simple statistics can be computed including
95% confidence intervals. These statistics need to be interpreted with caution. For ex-
ample, 95% confidence intervals for R derived from our bootstrap sample of R should
be interpreted as containing 95% of future estimates when the same assumptions are
made and the only noise source is observation error. It is tempting but incorrect to
interpret these confidence intervals as containing the true parameters with probability
0.95. Figure 2 shows the temporal distributions of the reproduction number and the
proportion of the clinical reporting obtained by the bootstrap method after fitting the
complex SEIR epidemic model to the initial phase of the Fall influenza wave using 17
epidemic days of the Spanish Flu Pandemic in San Francisco, California.
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4 Primer of mathematics and statistics of R0 and
R(t)
In addition to the estimation of R0, it is of practical importance to evaluate time-
dependent variations in the transmission potential. Explanation of the time course of
an epidemic can be partly achieved by estimating the effective reproduction number,
R(t), defined as the actual average number of secondary cases per primary case at
time t (for t > 0) [41][42][44][81][82]1. Although effective interventions against Spanish
influenza may have been limited in the early 20th century, it is plausible that the contact
frequency leading to infection varied with time owing to the huge number of deaths
and dissemination of information through local media (e.g. newspapers). R(t) shows
time-dependent variation with a decline in susceptible individuals (intrinsic factors)
and with the implementation of control measures (extrinsic factors). If R(t) < 1, it
suggests that the epidemic is in decline and may be regarded as being under control at
time t (vice versa, if R(t) > 1).
4.1 Estimation of R0 using the intrinsic growth rate
To appropriately understand the theoretical concept of R(t), let us firstly consider
an explicitly infection-age structured epidemic model. Whereas Kermack-McKendrick
model governed by ODEs (i.e. SIR and SEIR models as discussed above) has been well-
known, Kermack and McKendrick had actually proposed an infection-age structured
1
R(t) should not be confused with the number of removed individuals using the same notation. In
the following arguments of this paper, R(t) denotes the effective reproduction number.
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model in their initial publication in 1927 [72], the mathematical importance of which
was recognized only after 1970s [83][84]. Let us denote the numbers of susceptible and
recovered individuals by S(t) and U(t). Further, let i(t, τ) be the density of infectious
individuals at time t and infection-age τ (i.e. time since infection). The model is
given by
dS(t)
dt
= −λ(t)S(t)(
∂
∂t
+
∂
∂τ
)
i(t, τ) = −γ(τ)i(t, τ)
i(t, 0) = λ(t)S(t)
dU(t)
dt
=
∫∞
0
γ(τ)i(t, τ) dτ
(17)
where λ(t) is referred to as the force of infection (foi) (i.e. as discussed in Section 2,
foi is defined as the rate at which susceptible individuals get infected) which is given
by:
λ(t) =
∫ ∞
0
β(τ)i(t, τ) dτ (18)
and γ(τ) is the rate of recovery at infection-age τ . It should be noted that the above
model has not taken into account the background host demography (i.e. birth and
death). In a closed population, the total population size N is thus given by:
N = S(t) +
∫ ∞
0
i(t, τ) dτ + U(t) (19)
It should also be noted that, although i(t, τ) is referred to as density, it is not meant
to be a normalized density (i.e. integral of i(t, τ) over t and τ does not sum up to
1). Rather, we use density to mathematically refer to the absolute frequency in the
infection-age space.
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The system (17) can be reasonably integrated
i(t, τ) =


Γ(τ)j(t− τ), for t− τ > 0
Γ(τ)
Γ(τ − t)
j0(τ − t), for τ − t > 0
(20)
where
j(t) = i(t, 0)
Γ(τ) = exp
(
−
∫ τ
0
γ(σ) dσ
) (21)
and j0(τ) suggests the density of initially infected individuals at the beginning of an
epidemic. In the following arguments, we call j(t) as incidence of infection (i.e. new
infections at a given point of time t). It is not difficult to derive
S(t) = S(0)−
∫ t
0
j(σ) dσ (22)
from (17)- (21). Thus, the subequation of i(t, 0) in system (17) is rewritten as
j(t) = λ(t)
[
S(0)−
∫ t
0
j(σ) dσ
]
(23)
Taking into account the initial condition in (20), equation (22) is rewritten as
j(t) =
[
S(0)−
∫ t
0
j(σ) dσ
] [
G(t) +
∫ t
0
ψ(τ)j(t− τ) dτ
]
(24)
where
ψ(τ) = β(τ)Γ(τ)
G(t) =
∫∞
0
β(σ + t)
Γ(σ + t)
Γ(σ)
j0(σ) dσ
(25)
Considering the initial invasion phase (i.e. initial growth phase of an epidemic), we
get a linearized equation
j(t) = S(0)G(t) + S(0)
∫ t
0
ψ(τ)j(t− τ) dτ (26)
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The equation (26) represents Lotka’s integral equation, where the basic reproduction
number, R0, is given by
R0 = S(0)
∫ ∞
0
ψ(τ) dτ (27)
Thus, the epidemic will grow if R0 > 1 and decline to extinction if R0 < 1. The above
model can yield the same final size equation as seen in models governed by ODEs [17].
Assuming that the infection-age distribution is stable, we get a simplified renewal
equation
j(t) =
∫ ∞
0
A(τ)j(t− τ) dτ (28)
where A(τ) is the product of ψ(τ) and S(0). Moreover, assuming that we observe an
exponential growth of incidence during the initial phase (ı.e. j(t) = k exp(rt) where k
and r are, respectively, a constant (k > 0) and the intrinsic growth rate), the following
relationship must be met
j(t) = j(t− τ) exp(rτ) (29)
Replacing j(t− τ) in the right hand side of (28) by (29), we get
j(t) =
∫ ∞
0
A(τ)j(t) exp(−rτ) dτ (30)
Removing j(t) from both sides of (30), we get the Lotka-Euler characteristic equation:
1 =
∫ ∞
0
e−rτA(τ), dτ (31)
Further, we consider a probability density of the generation time (i.e. the time from
infection of an individual to the infection of a secondary case by that individual [85]),
denoted by w(τ):
w(τ) :=
A(τ)∫∞
0
A(x)dx
=
A(τ)
R0
. (32)
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Using (32), the equation (31) can be replaced by
1
R0
=
∫ ∞
0
exp(−rτ)w(τ), dτ (33)
The equations (29)-(33) are what Wallinga and Lipsitch discussed in a recent study
[6], reasonably suggesting the relationship between the generation time and R0. Ac-
cordingly, the estimator of R0 using the intrinsic growth rate is given by:
Rˆ0 =
1
M(−r)
, (34)
where M(−r) is the moment generating function of the generation time distribution
w(τ), given the intrinsic growth rate r [6] 2. Equation (34) significantly improved the
issue of estimating R0 using the intrinsic growth rate alone, because (34) permits val-
idating estimates of R0 by various different distributional assumptions for w(τ). The
issue of assuming explicit distributions for latent and infectious periods has been high-
lighted in recent studies [86][87][88][89],[90] and indeed, this point is in part addressed
by (34), because the convolution of latent and infectious periods yields w(τ). Moreover,
since the assumed lengths of generation time most likely yielded different estimates of
R0 for Spanish influenza by different studies [60], equation (34) highlights a critical
2In the original study of Wallinga and Lipsitch [6], the notation R0 is not used for equation (34)
and rather document (34) as the estimator of R. Most likely, there are two reasons for this. First,
we cannot assure if all individuals are susceptible to pandemic influenza before the start of epidemic
(as discussed in Section 2). Second, we cannot assume that infection-age distribution is stable during
the initial growth phase, which is highlighted in (20). Thus, it should be remembered that the above
discussion is mathematically tight in theory, but there are certain number of assumptions to apply the
concept to observed data. Since writing R alone is always confusing (as it is unclear if R is concerned
with time or immunity status), here we use R0 instead.
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need to clarify the generation time distribution using observed data.
Here we briefly show a numerical example. Figure 3 shows the daily number of
influenza deaths during Spanish influenza pandemic in a suburb of Zurich, 1918 [91].
Since the non-linear phase is difficult to analyze, our interest to estimate R0 with this
dataset is limited to the initial growth phase only (right panel in Fig 3). Even though
the data represent deaths over time (i.e. not infection events with time), we can di-
rectly extract the same intrinsic growth rate as practised with onset data, assuming
that death data are a good proxy for morbidity data (see our discussions in Section 6).
Assuming exponential growth in deaths as shown in (29), the intrinsic growth rate r is
estimated to be 0.16 per day. Supposing that w(τ) is arbitrarily assumed to follow a
gamma distribution with mean G and coefficient of variation, CV =
√
V ar(G)/G, R0
is given by
R0 = (1 + rG(CV )
2)
1
(CV )2 (35)
Although there is no concensus regarding the generation time of Spanish influenza, we
assume it ranges from 2-5 days. Assuming further that CV = 0.5, R0 is estimated to
range from 1.36 (for G = 2 day) to 2.07 (for G = 5 days).
4.2 The concept of R(t) and its estimation
In the following, let us consider the non-linear phase of an epidemic. Derivation of R0
given by (34) assumes an exponential growth which is applicable only during the very
initial phase of an epidemic (or, when the transmission is stationary over time), and
thus, it is of practical importance to widen the utility of above-described renewal equa-
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tions in order to appropriately interpret the time-course of an influenza pandemic. Let
us explicitly account for the depletion of susceptible individuals, as we deal with an es-
timation issue with time-inhomogeneous assumptions (ı.e. non-linear phase). Adopting
the mass action assumption, we get:
j(t) = S(t)
∫ ∞
0
ψ(τ)j(t− τ) dτ
=
∫ ∞
0
A(t, τ)j(t− τ) dτ
(36)
where A(t, τ) should be interpreted as the reproductive power at time t and infection-
age τ at which an infected individual generates secondary cases. We refer to the latter
part of equation (36) as a non-autonomous renewal equation, where the number of new
infection at time t is proportional to the number of infectious individuals (as assumed
in the renewal equation in the initial phase).
Using equation (36), the effective reproduction number, R(t) (i.e. instantaneous
reproduction number at calendar time t) is defined as:
R(t) =
∫ ∞
0
A(t, τ) dτ (37)
Following (37), we can immediately see that R(t) with an autonomous assumption (i.e.
where contact and recovery rates do not vary with time) is given by:
R(t) =
S(t)
S(0)
R0 (38)
which is shown in [17]. In practical terms, equation (38) suggests that time-varying de-
crease in transmission potential as well as decline in the epidemic reflects only depletion
of susceptible individuals. This corresponds to a classic assumption of the Kermack
and McKendrick model.
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However, as we discussed in the beginning of this section, we postulate that human
contact behaviors (and other extrinsic factors) modifies the dynamics of pandemic
influenza, assuming that the decline in incidence does reflect not only depletion of
susceptibles but also various extrinsic dynamics (e.g. isolation, quarantine and clo-
sure of public buildings). Thus, instead of the assumption in (36), we shall assume
time-inhomogeneous ψ(t, τ); i.e.
j(t) = S(t)
∫ ∞
0
ψ(t, τ)j(t− τ) dτ
=
∫ ∞
0
A(t, τ)j(t− τ) dτ
(39)
to describe A(t, τ).
To derive simple estimator of R(t), it is convenient to assume separation of vari-
ables for A(t, τ) (implicitly assuming that the relative infectiousness to infection-age is
independent of calendar time) [92]. Under this assumption, A(t, τ) is rewritten as the
product of two functions φ1(t) and φ2(τ):
A(t, τ) = φ1(t)φ2(τ) (40)
Arbitrarily assuming a normalized density for φ2(τ), i.e.,
∫ ∞
0
φ2(τ) dτ ≡ 1 (41)
then, it is easy to find that
R(t) =
∫ ∞
0
A(t, τ) dτ = φ1(t) (42)
suggesting that the function φ1(t) is equivalent to the effective reproduction number
R(t). Another function φ2(τ) represents the density of infection events as a function
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of infection-age τ . Accordingly, we can immediately see that φ2(τ) is exactly the same
as w(τ), the generation time distribution. That is, the above arguments suggest that
A(t, τ) (i.e. the rate at which an infectious individual at calendar time t and infection-
age τ produces secondary transmission) is decomposed as:
A(t, τ) = R(t)w(τ) (43)
Inserting (43) into (39) yields an estimator of R(t) [92]:
Rˆ(t) =
j(t)∫∞
0
j(t− τ)w(τ) dτ
(44)
The above equation (44) is exactly what was proposed in applications to SARS [41]
and foot and mouth disease [93]; i.e. discretizing (44) to apply it to the daily incidence
data (i.e. using ji incident cases infected between time ti and time ti+1 and descretized
generation time distribution wi),
Rˆ(ti) =
ji∑n
j=0 ji−jwj
(45)
was used as the estimator. However, it should be noted that the study in SARS
implicitly assumed that onset data c(t) at time t reflects the above discussed infection
event j(t). That is, supposing that we observed ci onset cases reported between ti and
ti+1, R(t) was calculated as
Rˆ(ti) =
ci∑n
j=0 ci−jsj
(46)
where sj is the discretized serial interval which is defined as the time from onset of a
primary case to onset of the secondary cases [94][95]. The method permits reasonable
transformation of an epidemic curve (i.e. temporal distribution of case onset) to the
27
estimates of time-inhomogeneous reproduction number R(t). Employing the relative
likelihood of case k infected by case l using the density function of serial interval s(t);
i.e.,
p(k,l) =
s(tk − tl|θ)∑
m6=k s(tk − tm|θ)
(47)
Using (47), expected value and variance of R(ti) are given by the following
E(R(ti)) =
1
n2t
∑
l:tl=t
n−q∑
k=1
p(k,l)
V ar(R(ti)) =
1
n2t
n−q∑
k=1
(∑
l:tl=t
p(k,l)(1− p(k,l))−
∑
l,m:tl=tm=t
p(k,l)p(k,m)
) (48)
where nt is the total number of reported case onsets at time t [96].
In the present day, only by using the above described methods (or similar concepts
with similar assumptions), we can transform epidemic curves into R(t) and roughly
assess the impact of control measures on an epidemic. However, whereas the equations
(45) and (46) are similar in theory, we need to explicitly account for the difference be-
tween onset and infection event. In fact, when there are many asymptomatic infections
and asymptomatic secondary transmissions, serial interval is not equivalent to the gen-
eration time, and thus, directly adopting the above methods would be inappropriate.
Since this point is particularly important in analyzing influenza data, we discuss this
issue in Section 6.
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5 Statistical methods to estimate R0
5.1 Branching process
In the previous sections, we discussed several different methods to estimate R0 either by
(i) employing detailed curve fitting method assuming a structured epidemic model or
(ii) using the intrinsic growth rate (or doubling time [97][98]). Summarizing the above
discussions, we believe that the readers should benefit from memorizing R0 = 1/M(−r)
for the use of the intrinsic growth rate r in estimating R0 [6] and remembering the final
size equation R0 = − ln(1−p)/p suggesting the severity of an epidemic as the theoretical
concept. Indeed, estimator using either the intrinsic growth rate or final size has still
continued to play an important role in discussing R0 of pandemic influenza [63].
However, it should be noted that deterministic models do not permit incorporating
stochasticity explicitly (e.g. standard error for R0 is determined by measurement of
errors alone), as the models argue only average number of secondary transmissions
within the assumed transmission dynamics. That is, our arguments given above explore
only the time-evolution of influenza spread in the mean field. To address the issue of
variation in secondary transmissions, full stochastic models are called for [99].
From a viewpoint of data science, the discrete-time branching process, which is also
referred to as Galton-Watson process, can reasonably assess individual heterogeneity
in secondary transmissions [100][101]. As we discussed the initial growth phase of
the deterministic model, let us consider the same epidemic phase where we observe a
geometric increase in the number of cases by generation [23]. We denote the initial
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number of infected individuals by C0 in generation 0. Then, during the first generation,
C1 cases are produced by secondary transmissions of C0. Similarly, let Cn be the
number of infections in generation n. The branching process of this type assumes that
every infected individual has an independently and identically distributed stochastic
random variable ρ
(n)
i representing the number of secondary cases produced by case i in
generation (n), and that environmental stochasticity and immigration/emigration can
be ignored. Supposing that the pattern of secondary transmission follows a discrete
probability distribution pk with k secondary transmission(s); i.e.,
pk = Pr(ρ
(n)
i = k) (k = 0, 1, 2, ...) (49)
then, the expected number of secondary transmissions and the variance are given by
R0 = E(ρ
(n)
i ) =
∑∞
k=1 kpk
V ar(ρ
(n)
i ) =
∑∞
k=0 (k − R0)
2 pk
(50)
In other words, the concept of probability distribution pk reflects offspring dis-
tribution in population ecology, and this permits explicit modeling of variations in
secondary transmissions in infectious diseases [102][103]. This approach is particularly
important during the initial phase of an epidemic, because the number of infectious
individuals is small in this stage, and thus, it is deemed essential to take into account
demographic stochasticity, i.e., variation in the numbers of secondary transmissions
by chance. Indeed, the model has been applied to observed outbreak data where we
observed the extinction before growing to a major epidemic [104][105].
Let us briefly discuss the variation in secondary transmissions and an estimation
method of R0 using the discrete-time branching process, deriving analytical expres-
30
sions of the expected number of infected individuals in generation n, Mn = E(Cn) and
the variance Vn = V ar(Cn). It is impossible to avoid using the probability generating
function (pgf) to discuss the branching process. The above described ρ
(n)
i character-
ize positive and discrete number of secondary transmissions, and thus, is a non-zero
discrete random variable. The pgf of ρ, gρ(s) is given by
gρ(s) = E(s
ρ) =
∞∑
k=0
pks
k (51)
There are two basic properties concerning g(s) in relation to the epidemic process.
First, R0 is by definition the mean value of secondary transmissions (equation (50))
and, thus given by g′(1). Second, the probability that an infected individual does not
cause any secondary transmissions p0 = Pr(ρ=0) is given by g(0), which is useful for
discussing threshold phenomena and extinction [101]. If we note that C0 = 1 (i.e. only
one index case), the Galton-Watson process has the following pgf identity:
g0(s) = s
gn+1(s) = gn(g(s)) = g(gn(s))
(52)
Even when there are C0 = a cases in generation 0 (where a > 1), we just have to
assume that there are a different independent infection-trees and thus
gC0(s) = s
a
gCn(s) = (gn(s))
a
(53)
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From the above discussions, the expected number of cases in generation n, Mn, and
the variance Vn is
Mn = R
n
0M0
Vn =


nV ar(ρ), (R0 = 1)
Rn−10 V ar(ρ)
Rn0 − 1
R0 − 1
, (R0 6= 1)
(54)
The process grows geometrically if R0 > 1, stays constant if R0 = 1, and decays ge-
ometrically if R0 < 1. These three cases are referred to as supercritical, critical,
and subcritical, respectively. However, unlike the deterministic model, it should be
remembered that critical process does not permit continued transmissions, and rather,
the process becomes extinct almost surely (i.e. probability of extinction given R0 = 1
is one) [101].
Mathematically, demographic stochasticity in transmission is represented by a Pois-
son process, which has been practiced in the application of branching processes to epi-
demics [17]. Assuming that mean value of secondary transmissions is a constant R0,
the conditional distribution of observing Cn+1 cases, given Cn cases, follows a Poisson
distribution:
Cn+1|Cn ∼ Poisson [CnR0] (55)
Supposing that we analyze influenza data documenting the generations of cases from
0 to n in which we observed geometric growth, the likelihood of estimating R0 is
proportional to
n∏
k=1
(R0Ck−1)
Ck exp (−R0Ck−1) (56)
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Here we apply the above model to the Spanish influenza data in Zurich (Figure 3).
Assuming that the generation time of length τ , w(τ), is given by the following delta
function with the mean length 3 days,
w(τ) =


∞, for τ = 3
0, for τ 6= 3
(57)
then the observed series of data can be grouped by generation (C0, C1, C2, ...):
1, 3, 4, 7, 26, 30, 37, ... (58)
Since we assumed exponential growth during the initial 16 days in the previous sec-
tion, here we similarly assume a geometric increase up to the 6th generation. Applying
(56) to the above data, maximum likelihood estimate of R0 (and the corresponding
95 percent confidence intervals) is 1.51 (1.24, 1.81). The model is simple enough to
estimate R0, and indeed, a slight extension of the discrete-time branching process has
been employed to estimate R0 as well as the proportion of undiagnosed cases in the
analysis of SARS outbreak data [106].
It should be noted that the discrete-time branching process assumes homogeneous
pattern of spread. A technical issue has arisen on this subject during the SARS out-
break. Usually, we observe some cases who produce an extraordinary number of sec-
ondary cases compared with other infected individuals, which are referred to as super-
spreaders. Because of this, observed offspring distributions for directly transmitted
diseases tend to be extremely skewed to the right. Empirically, it has been suggested
that Poisson offspring distribution is sometimes insufficient to highlight the presence
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of superspreaders in epidemic modeling [107]. For example, if non-zero discrete dis-
tribution of secondary cases follows a geometric distribution with mean R0, the pgf is
given by a geometric distribution with mean R0:
g(s) =
1
1 +R0(1− s)
(59)
Moreover, if the offspring distribution follows gamma distribution with mean R0 and
dispersion parameter k, the pgf g(s) follows negative binomial distribution [108]:
g(s) =
(
1 +
R
k
(1− s)
)−k
(60)
We still do not know if pandemic influenza is also the case to warrant the skewed
offspring distributions. To explicitly test if superspreading events frequently exist in
influenza transmission, it is necessary to accumulate contact tracing data for this dif-
ficult disease, the cases of which often show flu-like symptoms only (as discussed in
Section 1). In addition, it should be noted that we cannot attribute the skewed off-
spring distribution to the underlying contact network only. To date, there are two
major reasons which can generate superspreaders: (i) those who experience very fre-
quent contacts (social superspreader) or (ii) those who are suffering from high pathogen
loads or those who can scatter the pathogen through the air such as the use of nebuliser
in hospitals (biological superspreader). From the offspring distribution only, we cannot
distinguish these two mechanisms.
5.2 Counting process
With regard to the estimation of R0 using final size, we briefly discuss another method
based on a stochastic process. As we discussed above, let S(t), I(t) and U(t) be the
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numbers of susceptible, infectious and recovered individuals at time t, respectively.
Further, let β and 1/γ denote the transmission rate and the mean duration of the
infectious period, respectively. Supposing that K(t), the number of individuals who
experienced infection between time 0 and time t, is given by K(t) = S(0) − S(t),
the two processes K(t) and U(t) are increasing counting processes where the general
epidemic is explained by:
Pr(dK(t) = 1, dU(t) = 0|Zt) = βS¯(t)I(t)dt
Pr(dK(t) = 0, dU(t) = 1|Zt) = γI(t)dt
Pr(dK(t) = 0, dU(t) = 0|Zt) = 1− βS¯(t)I(t)dt− γI(t)dt
(61)
where Zt denotes the σ-algebra generated by the history of the epidemic {S(u), I(u); 0 < u < t}
and S¯(t) = S(t)/n (where n is the size of the susceptible population at time 0). The
latter is equivalent to assuming density-independent transmission (i.e. also referred
to as true mass action or frequency dependent assumption [109]). Based on equation
(61), two zero-mean martingales [110] are defined by:
M1(t) = K(t)−
∫ t
0
βS¯(u)I(u) du
M2(t) = U(t)−
∫ t
0
γI(u) du
(62)
From the martingale theory [111], a zero-mean martingale is given by
M(t) =
∫ t
0
1
S¯(u)
dM1(u)−
β
γ
M2(t)
=
n
S(0)
+
n
S(0)− 1
+ ... +
n
S(t) + 1
−
β
γ
U(t)
(63)
Thus, the estimator θˆ = βˆ/γˆ is given by
θˆ =
[
n
S(0)
+
n
S(0)− 1
+ ... +
n
S(T ) + 1
]
U(T )
=
−ln(1− p˜)
U(T )
(64)
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where p˜ is the observed final size (= 1 − S(T )/n) at the end of the epidemic at time
T . Furthermore, the variance of the zero-martingale is given by
V ar(M(t)) = V ar(M1(t)) + θ
2V ar(M2(t)) (65)
From the martingale central limit theorem [112], the estimator θ is approximately
normally distributed in a major outbreak in a large community. The standard error is
then consistently estimated by:
s.e.(θˆ) =
[
n
S(0)2
+
n
(S(0)− 1)2
+ ...+
n
(S(T ) + 1)2
− θˆ2R(T )
]1
2
U(T )
=

 n
S(0) +
1
2
+
n
S(0) +
1
2
− θˆ2R(T )


1
2
U(T )
(66)
Consequently, the estimator and standard error of R0 are given by:
Rˆ0 = n× θˆ
s.e.(Rˆ0) = n× s.e.(θˆ)
(67)
More detailed mathematical descriptions can be found elsewhere [74][113][114].
Here we show a numerical example. Let us consider a large epidemic of equine
influenza (i.e. influenza in horses) as our case study. In 1971, a nationwide epidemic
of equine-2 influenza A (H3N8) was observed in Japan [115]. For example, in Niigata
Racecourse, 580 influenza cases were diagnosed with influenza among a total of 640
susceptible horses. The final size p is thus 90.6 percent (95 percent CI: 88.4, 92.9).
From this data, we calculate R0 and its uncertainty bounds.
Using p˜ = 0.906 and total number of infected U(T ) = 580 in equation (64), θˆ is
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estimated as 0.00408. Therefore, the estimate of R0 = 2.60 is given by equation (67).
Moreover, from equation (66) where S(T ) = 639− 579 = 60 and S(0)(= n) = 639 (we
assume one case was already infected at time t = 0), we obtain s.e.(θˆ) = 0.000126.
Here, θˆ is assumed to follow normal distribution. Therefore, the 95 percent confidence
interval for R0 is given as [R0 − 1.96× 640× 0.000126, R0 + 1.96× 640× 0.000126] =
[2.44, 2.76].
When applying the final size equation, it should be remembered that (i) we assume
all individuals are initially susceptible (in the above described model) and (ii) we
assume β and γ are independent of time (i.e. constant), and thus, that any extrinsic
factors should not have influenced the course of the observed epidemic.
5.3 Epidemics with two levels of mixing
In the above described models, we always assumed that the pattern of influenza trans-
mission is homogeneous, which is clearly unrealistic to capture the transmission dy-
namics of influenza. Since the last century, it has already been understood that the
transmission dynamics are not sufficiently modeled by assuming homogeneous mixing.
However, because more detailed data are lacking (e.g. epidemic records of pandemic
influenza with time, age and space), what we could offer has been mainly to extract
the intrinsic growth rate from the initial exponential growth, and estimate R0 using
the estimator based on a model with the homogeneous mixing assumption.
One line of addressing heterogeneous patterns of transmission using the observed
data is separating household transmission from community transmission. In other
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words, it is of practical importance to distinguish between individual and group R0
[116]. From the beginning of explicit modeling of influenza [117][118], a method to
separately estimate the transmission parameters has been proposed, which has been
partly extended in a recent study [92] or applied to further old data of pandemic in-
fluenza [119]. Indeed, an important aspect of this issue was highlighted in a recent
study which compared estimates of R0 between those having casual and close contacts
[63]. To estimate key parameters of household and community transmissions of in-
fluenza, or to simulate realistic patterns of influenza spread, such a consideration is
fruitful.
Mathematically elaborating this concept, there are several publications which pro-
posed the basis of analyzing household transmission data employing stochastic models
[120][121][122]. Moreover, a rigorous study has been made to estimate parameters de-
termining the intrinsic dynamics (e.g. infectious period) using household transmission
data with time [123].
Future challenges on the estimation of R0 include the application of such theo-
ries to the observed data with some extension. For example, as we discussed above,
knowing the generation time would be crucial to elucidate a robust estimate of R0
[6][89][92][90]. However, we do not know if the generation time varies between close
and casual contacts; this should be the case, because, as long as the generation time
is given by covolution of latent and infectious periods, close contact should lead to
shorter generation time than casual contact. In future studies, influenza models may
better to highlight the increasing importance of considering household transmission to
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estimate the transmission potential using the temporal distribution of infection events.
6 Characteristics of influenza data
Except for our approach in Section 3, mathematical arguments given in this paper
are not particularly special for influenza. In other words, we modelers have employed
similarly structured models which describe the population dynamics of other directly
transmitted diseases, and such models are applicable not only for influenza but also
for many viral diseases including measles, smallpox, chickenpox, rubella and so on
[18]. However, influenza has many different epidemiologic characteristics compared
to other childhood viral diseases. For instance, following the previous efforts in in-
fluenza epidemiology [124][125][126] and modeling [127][128], we should at least note
the following:
1. Detailed mechanisms of immunity have yet to be clarified. Since influenza virus
has an wide antigenic diversity (i.e. unlike other childhood viral diseases, anti-
genic stimulation is not monoclonal), this complicates our understanding in the
fraction of immune individuals, cross-protection mechanisms and evolutionary
dynamics [129][130][131][132].
2. Flu-like symptoms are too common, and thus, we cannnot explicitly distinguish
influenza from other common viral infections without expensive laboratory tests
for each case. Because of this character, it is difficult to effectively implement
usual public health measures (e.g. contact tracing and isolation).
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3. Although explicit estimates are limited [133][134], a certain fraction of infected
individuals does not exhibit any symptoms (following infection). This compli-
cates not only the eradication [135] but also epidemiologic evaluations of vaccines
and therapeutics [136].
4. Looking into the details of the intrinsic dynamics [4][123], it appears recently
that the generation time and infectious period are much shorter than what were
believed previously. Therefore, despite the relatively small R0 estimate, the turn-
over of a transmission cycle (i.e. speed of growth) is rather quick. The incubation
period of Spanish influenza is as short as 1.5 days [137], complicating the imple-
mentation of quarantine measures [138].
Thus, depending on the characteristics of observed data (and the specific purpose of
modeling), we have to highlight these factors referring to the best available evidence.
This is one of the most challenging issues in designing public health interventions
against a potential future pandemic.
6.1 What is reported in the observed data?
In addition to the above described issue, we, of course, must remember what the re-
ported data is. In many studies, the compartment I(t) or relevant class of infectious
individuals of the SIR (or SEIR) model was fitted to the observed data. Indeed, in the
majority of previous classic studies, R(t) (i.e. removed class; denoted by U(t) in our
discussion) of Kermack and McKendrick model was fitted to the data, assuming that
the removed class highlights observed data as the reported cases no longer produce
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secondary cases. However, the observed epidemiologic data is actually neither I(t) nor
U(t). Always, what we get as the temporal distribution reflects case onset or deaths
with time which is mostly accompanied by some reporting delay.
We believe this is one of the most challenging issues in epidemic modeling. Ex-
cept for rare examples in sexually transmitted diseases, infection event is not directly
observable, and thus, we have to maximize the utility of reported (observed) data,
explicitly understanding what the data represents.
In this case, back-calculation of the infection events is called for. Let c(t) denote
the number of onsets at time t, this should be modeled by using incidence j(t) and the
density of the incubation period of length τ , f(τ):
c(t) =
∫ ∞
0
j(t− τ)f(τ) dτ (68)
Further, supposing that b(t) is the number of reported cases at time t and the density
of reporting delay of length σ is h(σ), observed data is modeled as:
b(t) =
∫∞
0
c(t− s)h(s) ds
=
∫∞
0
∫∞
0
j(t− s− τ)f(τ) dτh(s) ds
(69)
That is, only by using the observed data b(t) and known information of the reporting
delay h(s) and incubation period distributions f(τ), we can translate the observed data
into infection process j(t).
In some cases, only death data with time, d(t), is available [60]. Similarly, this
can be modeled using the backcalculation. Let q denote the case fatality of influenza
which is reasonably assumed time-independent, and further let m(u) be the relative
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frequency of time from onset to death, d(t) is given by:
d(t) = q
∫ ∞
0
c(t− u)m(u) du (70)
Even when using onset data with delay or death data, it should be noted that the
intrinsic growth rate is identical to that estimated from the infection event distribution.
Assuming that the incidence j(t) exhibits exponential growth during the initial phase
of an epidemic, i.e., j(t) = k exp(rt), equations (68) and (70) can be rewritten as
b(t) =
∫∞
0
∫∞
0
k exp(r(t− s− τ))f(τ) dτh(s) ds
= k exp(rt)
∫∞
0
∫∞
0
exp(−r(s+ τ))f(τ) dτh(s) ds
(71)
and
d(t) = q
∫∞
0
∫∞
0
j(t− u− τ)f(τ) dτm(u) du
= q
∫∞
0
∫∞
0
k exp(r(t− u− τ))f(τ) dτm(u) du
= qk exp(rt)
∫∞
0
∫∞
0
exp(−r(u+ τ))f(τ) dτm(u) du
(72)
Thus, the growth terms exp(rt) (i.e. which depends on time) of b(t) and d(t) are still
identical to that of incidence j(t). In other words, mathematically the equations (71)
and (72) could be a justification to extract an estimate of the intrinsic growth rate from
cases with reporting delay or deaths with time. However, we should always remember
that the infection-age distribution is not stable during the initial phase, and moreover,
this method cannot address individual variation in the secondary transmissions (e.g.
superspreaders, as we discussed in Section 5).
6.2 What to be learnt from the reported data?
In this way, it’s not an easy task to clarify the infection events with time. A simi-
lar application of the convolution equation has been intensively studied in modeling
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HIV/AIDS. Since AIDS has a long incubation period, and because AIDS diagnosis
is certainly reported in the surveillance data (at least, in industrialized countries),
backcalculation of the number of HIV infections with time using the nubmer of AIDS
diagnoses and the incubation period distribution has been an issue to capture the whole
epidemiologic picture of HIV/AIDS [139][140][141][142]. In the current modeling prac-
tice using the temporal distribution of onset events, we are now faced with a need to
apply this technique to diseases with much shorter incubation periods.
Now, let’s look back at a method to estimate R(t), which was proposed by Wallinga
and Teunis [41]. Whereas the method has a background of mathematical reasoning
(as shown in (46), Section 4.2), the estimator was derived implicitly assuming that
observed data exactly reflects infection events. If asymptomatic infection and transmis-
sion are rare, this assumption might be justifiable as the lengths of the serial interval
and generation time become almost identical. However, as long as we cannot ignore
asymptomatic transmissions, which is particularly the case for influenza, the assump-
tion s(σ) = w(τ) might be problematic [85].
Since R(t) of this method was given by summing up the probability of causing
secondary transmissions by an onset case at the onset time of this case t, we should
rewrite the assumption using a modified onset-based renewal equation as follows [60]:
c(t) =
∫ t
0
c(t− τ)R(t− τ)s(τ) dτ (73)
For simplicity, we ignore reporting delay in the observed data, roughly assuming that
the observed data reflects c(t). Translating equation (73) in words, it is implicitly
assumed that secondary transmission happens exactly at the time of onset, and based
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on this assumption, R(t) in the right hand side of (73) can be backcalculated.
To understand the assumptions behind the above equation, let us assume that
incidence j(t) is given by
j(t) = S(t)
∫ ∞
0
β(σ)Γ(σ)c(t− σ) dσ (74)
where β(σ) is the transmission rate at disease-age σ (i.e. the time since onset of
infection [143]) and Γ(σ) is the survivorship of cases following onset. It should be
noted that equation (74) ignores secondary transmissions before onset of illness. As
we discussed above, c(t) is given by j(t) and the incubation period distribution f(τ),
c(t) =
∫ ∞
0
j(t− τ)f(τ) dτ (75)
Replacing c(t) in the right hand side of (74) by (75), we get
j(t) = S(t)
∫ ∞
0
j(t− s)φ(s) ds (76)
where s represents infection-age (i.e. time since infection), and φ(s) is given by
φ(s) =
∫ s
0
β(a)Γ(a)f(s− a) da (77)
which represents generation time distribution. From equations (76) and (77), we can
find that R(t) is given by
R(t) = S(t)
∫∞
0
φ(s) ds
= S(t)
∫∞
0
β(σ)Γ(σ) dσ
∫∞
0
f(τ) dτ
(78)
Equation (78) can be further reduced to R(t) = R0S(t)/S(0) which represents Kermack
and McKendrick’s assumption. Replacing j(t) in the right hand side of (75) by (74),
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we get
c(t) =
∫ ∞
0
ψ(t, σ)c(t− σ) dσ (79)
where ψ(t, σ) denotes the serial interval distribution of calender time t and disease-age
σ:
ψ(t, σ) =
∫ σ
0
β(σ − τ)Γ(σ − τ)f(τ)S(t− τ) dτ (80)
Equation (80) is difficult to solve as it includes S(t−τ) in the right hand side. However,
in the special case, e.g., let’s say when we can assume β(τ)Γ(τ) = kδ(τ) (where k is
constant and δ(·) is delta function),
ψ(t, σ) = kf(σ)S(t− σ) (81)
Inserting (81) back to (79),
c(t) =
∫∞
0
kf(σ)S(t− σ)c(t− σ) dσ
=
∫∞
0
R(t− σ)c(t− σ)
f(σ)∫∞
0
f(τ) dτ
dσ
(82)
which is onset-based renewal equation which was presented in (73). What to be learnt
from (82) is, the assumption that secondary transmission happens immediately after
onset suggests that the incubation period distribution is identical to the serial interval
distribution as shown above, which is a bit funny conclusion. Maximizing the utility of
observed data has still remained an open question.
In addition to modeling the temporal distribution, explicit modeling of asymp-
tomatic infection is also called for [135]. Provided that there are so many asymptomatic
transmissions which are not in the negligible order, we need to shift our concept of
transmissibility; e.g., rather than R0, a threshold quantity of symptomatic infection is
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required. In such a case, application of type-reproduction number T might be useful
[144][145], and it has already been put into practice [146].
7 What to be clarified further?
In this review, we focused on the use of the temporal distribution of influenza to
estimate R0 (or R(t)) and the relevant key parameters. It must be remembered that
our arguments, almost necessarily, employed homogeneous mixing assumption, as we
cannot extract information on heterogeneous patterns of infection from a single stream
of temporal data alone. Presently, more information (e.g. at least, spatio-temporal
distribution) is becoming available for influenza. In this section, we briefly sketch what
can be (and should be) done in the future to quantify the transmission dynamics of
pandemic influenza.
7.1 What R0 really means?
It’s not a new issue that heterogeneous patterns of transmission could even destroy the
mean field theory in infectious diseases. For example, in a pioneering study of gon-
orrhea transmission dynamics by Hethcote and Yorke [147], an importance of contact
heterogeneity was sufficiently highlighted. Since a simple model assuming homogeneous
mixing did not reflect the patterns of gonorrhea transmission in the United States, Het-
hcote and Yorke divided the population in question into two; those who are sexually
very active and not, the former of which was referred to as core group. Compared
with the temporal distribution of infection given by a model with homogeneous mixing
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assumption, the simple heterogeneous model with a core group revealed much quicker
increase in epidemic size, showing rather different trajectory of an epidemic. Given
that the variance of sexual partnership is extremely large (i.e. if the distribution of
the frequency of sexual intercourse is extremely skewed to the right with a very long
right tail), the estimate of R0 is shown to become considerably high. The finding sup-
ports a vulnerability of our society to the invasion of sexually transmitted diseases.
Following this pioneering study, considerable efforts have been made to approximately
model the heterogeneous patterns of transmission using extended mean field equations
[18][26][148][149].
In addition to such an approximation of heterogeneous transmission, recent progress
in epidemic modeling with explicit contact network structures suggests that vari-
ance of the contact frequency plays a key role in determining the threshold quantity,
and in some special cases, the concept of threshold phenomena could be confused
[150][151][152][153]. In Section 4, we defined the force of infection as
λ(t) =
∫ ∞
0
β(τ)i(t, τ) dτ (83)
In deteministic models given by simple ODEs (which ignores infection-age), λ(t) is
equivalent to βI(t). These are what classical mean field models suggest.
Let us account for an epidemic on networks, whose node-connectivity distribution
(i.e. the distribution of probabilities that nodes have exactly k neighbors) follows some
explicit distribution P (k). The force of infection λc, which yields R0 = 1, in a static
contact network is given by
λc =
〈k〉
〈k2〉
(84)
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Here 〈k〉 denotes the average connectivity of the nodes. Assuming that P (k) follows a
power law of the form P (k) = ck−v (where c is constant),
〈k2〉 = c
∑
k
k2−v (85)
Given that v ≤ 3, λc = 0, and in such a case, R0 even becomes infinite. This implies
that the disease spread will continue for any mean estimate of R0. Such a network
structure is referred to as scale free [154], complicating disease control efforts in public
health [155][156]. The importance of the network structure would also be highlighted
for v > 3.
For sexually transmitted infections, contact frequency is countable (unlike airborne
infection or transmission through droplets), and v is estimated to be around 3 or a
little larger [157]. Following such a finding, many non-sexual directly transmitted
diseases are also modeled in the present day assuming the scale-free network [150].
However, it should be noted that the pattern of contact does not necessarily follow
scale-free for all directly transmitted diseases. Indeed, there is no empirical evidence
which suggests that the contact structure of any droplet infections follows the power
law (i.e. we do not know if the above described contact heterogeneity is the case for
diseases except for sexually transmitted diseases). A typical example of confusion is
seen in the superspreading events during the 2002-03 SARS epidemics [158], where
we cannot explicitly attribute the phenomena either to contact network or biological
factors (as long as contact and infection event are not directly observable). We still
do not know how we should account for the distribution P (k) for influenza and other
viral respiratory diseases (i.e. power law or not) which remains to be clarified for each
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disease in future research.
7.2 New theory to replace mass action principle
Methodoligical developments have been made to account for the network heterogeneity
with data [159]. An approximate approach to address this issue is highlighted partic-
ularly in spatio-temporal modeling, an excellent account of which is reviewed by Matt
Keeling [160].
Even though it’s difficult to quantify the transmission dynamics with an explicit
contact network with time, there are useful analytical approximations to capture the
dynamics of influenza (and other respiratory transmitted viral diseases) and estimate
the transmission potential. For example, the force of infection with a power law ap-
proximation is reasonably given by:
λ(t) = βI(t)1+αS(t)1+Ψ (86)
In (86), α and Ψ characterize the epidemic dynamics; e.g. initial growth (i.e if α is
less than 0, the modified form acts to dampen the exponential growth of incidence)
and endemic equilibrium (i.e. when Ψ is greater than 0, density-dependent damping is
increased). A model of this type was actually validated with measles data in England
and Wales, comparing the prediction with that of employing the mass action principle
[161].
Another approximation might be a pair-wise model [162], which can explicitly ac-
count for the correlation between connected pairs. The model reasonably permits
deriving the force of infection λ using the number of various connected paris, which
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implies wide applicability to the epidemiologic data of sexually transmitted infections.
Incorporating spatial heterogeneity in an approximate manner would shed light on fur-
ther quantifications [163][164], and thus, simple and reasonably tractable models which
permit spatio-temporal modeling of influenza are expected (e.g. [165]).
7.3 Which kind of data do we have to explore?
Summarizing the above discussions, we have presented modeling approaches that can
quantify the transmission potential of pandemic influenza. As we have shown, temporal
case distributions have been analyzed in many instances, and previous efforts have come
close to maximize the utility of temporal distributions (i.e. epidemic curve). However,
at the same time, we have also learned that we can extract almost the intrinsic growth
rate alone from a single time-evolution data. Accordingly, we are now faced with a need
to clarify heterogeneous patterns of transmission and more detailed intrinsic dynamics
of influenza [166][167][168]. With regard to the latter, primitive epidemiologic questions
(e.g. probability of clinical attack given infection) remain to be answered for Spanish,
Asian and Hong Kong influenza. Let’s summarize what we need to clarify theoretically
about pandemic influenza in list:
1. Acquired immunity
2. Evolutionary dynamics
3. Multi-host species transmission
4. Asymptomatic transmission
50
5. Attack rate (i.e. Pr(onset|infection))
6. Case fatality (i.e. Pr(death|onset))
7. Generation time and serial interval
8. Latent, incubation, infectious and symptomatic periods with further data
9. Transmission potential with time, space and antigenic types
10. Transmission potential with time and age
These issues highlight an importance to quantify the transmission of influenza using
not only cases (i.e. those followed onset of symptoms) but also some hint suggesting the
infection event. For example, majority of the above listed issues could be reasonably
addressed by implementing serological surveys (e.g. antibody titers of individuals and,
preferably, time-delay delay distribution from infection to seroconversion). Since the
proportion of those who do not experience symptomatic infection (i.e. probability
of asymptomatic infection) is not small for influenza [64][146], case records can tell
us little to address the above mentioned issues, and thus, historical data of Spanish
influenza may hardly offer further information. By maximizing the utility of observed
data, we have to clarify the dynamics of influenza further, and identify key information
which characterize the specific mechanisms of spread.
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Table 1: Reported estimates of R0 for pandemic influenza during the fall wave (2nd
wave) from 1918-19
Location Serial interval R0 Autonomous system Reference
(days) fitted with entire
epidemic curve
San Francisco, USA 6 3.5 Yes [39]
6 2.4 No [39]
45 cities in the USA 6a 2.7 No [8]
UK (entire England and Wales)b 6 1.6 Yes [58]
Scandinavian cities 6 1.4-1.6 No [62]
Geneva, Switzerland 5.7 3.8 Yes [38]
Sao Paulo, Brazil 4.6 2.7 Yes [59]
cities in Europe and America 4.0 1.2-3.0 No [63]
83 cities in the UK 3.2, 2.6 1.7-2.0 No [5, 57]
45 cities in the USA 2.9 1.7 No [6]
RAF camp in the UK 2.3 2.9 No [64]
Featherston Military 1.6 3.1 Yes [61]
Camp, New Zealandc 1.1 1.8 Yes [61]
0.9 1.3 Yes [61]
aSensitivity of the R estimates to different assumptions for the serial interval was
examined; bThree pandemic waves were simultaneously fitted; cThe epidemic was
observed in a community with closed contact (i.e. military camp).
76
Figure 1: Flow chart of the state progression of individuals among the dif-
ferent epidemiological classes as modeled by the complex SEIR model. See
equations (10).
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Figure 2: Model fits, residuals plots, and the resulting distributions of the
reproduction number and the proportion of the clinical reporting obtained
after fitting the complex SEIR epidemic model to the initial phase of the
Fall influenza wave using 17 epidemic days of the Spanish Flu Pandemic in
San Francisco, California. See equations (10) [39]. In the top panel, the epidemic
data of the cumulative number of reported influenza cases are the circles, the solid line
is the model best fit, and the solid blue lines are 1000 realizations of the model fit to
the data obtained through parametric bootstrapping as explained in the main text.
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Figure 3: Temporal distribution of Spanish influenza in Zurich. Left panel
shows an epidemic curve (i.e. deaths distribution) of pandemic influenza in a suburb
of Zurich in 1918. In total, 259 deaths were observed from 9 July to 18 August. Right
panel shows observed and expected values of the cumulative number of deaths during
the first 16 days. The intrinsic growth rate is estimated to be 0.16 per day. Data
source: [91]
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